Delivery Order SPE2DR25D3012-SPE2DR26F4C8V
Award Date 12/4/25
Potential Completion Date 12/26/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,377.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), an antiviral medication used in medical treatment protocols. The contract, which is a child award under a larger indefinite delivery vehicle, was competitively awarded without set-aside designation and is scheduled for completion by May 12, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,962.20 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), a broad-spectrum antiviral medication. This firm fixed-price delivery order, issued on June 3, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive award under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Veklury (remdesivir) 100 mg vials, with a ceiling value of $5,010.48 and an ultimate completion date of December 1, 2025. This is a firm fixed-price delivery order awarded without set-aside designation, indicating competitive award based on the vendor's demonstrated capability to fulfill federal pharmaceutical procurement requirements. The place of performance is...
- The Defense Logistics Agency awarded a $4,175.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Veklury on December 9, 2025, with performance completion targeted for December 31, 2025. This non-set-aside contract is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Veklury (remdesivir) is an antiviral medication with established clinical applications, and this delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury (remdesivir) 100 mg vials valued at $15,848.80 under a firm fixed-price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $20,427.60 firm fixed price contract has an ultimate completion date of October 29, 2024. This award is a task order under AmerisourceBergen's Indefinite Delivery Contract valued up to $999,999,999 with DLA Troop Support Medical for a wide range of pharmaceutical and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 mg vials of the antiviral drug Veklury (Remdesivir). The $13,618.40 contract has an ultimate completion date of April 17, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- This is a $6,809.20 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Veklury (Remdesivir) 100 mg vials, a pharmaceutical product used for the treatment of COVID-19. The contract is a firm-fixed-price arrangement with an ultimate completion date of October 17, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,175.40 by the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Veklury 100 mg vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 29, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- This is a $13,618.40 delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The firm-fixed-price contract runs through July 25, 2024 and was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...